New perspective on parkinsonism in frontotemporal lobar degeneration - PubMed
Review
New perspective on parkinsonism in frontotemporal lobar degeneration
Hee Kyung Park et al. J Mov Disord. 2013 May.
Abstract
Frontotemporal dementia (FTD) is the second most common type of presenile dementia. Three clinical prototypes have been defined; behavioral variant FTD, semantic dementia, and progressive nonfluent aphasia. Progressive supranuclear palsy, corticobasal degeneration, and motor neuron disease may possess clinical and pathological characteristics that overlap with FTD, and it is possible that they may all belong to the same clinicopathological spectrum. Frontotemporal lobar degeneration (FTLD) is a clinicopathological syndrome that encompasses a heterogenous group of neurodegenerative disorders. Owing to the advancement in the field of molecular genetics, diagnostic imaging, and pathology, FTLD has been the focus of great interest. Nevertheless, parkinsonism in FTLD has received relatively less attention. Parkinsonism is found in approximately 20-30% of patients in FTLD. Furthermore, parkinsonism can be seen in all FTLD subtypes, and some patients with familial and sporadic FTLD can present with prominent parkinsonism. Therefore, there is a need to understand parkinsonism in FTLD in order to obtain a better understanding of the disease. With regard to the clinical characteristics, the akinetic rigid type of parkinsonism has predominantly been described. Parkinsonism is frequently observed in familial FTD, more specifically, in FTD with parkinsonism linked to chromosome 17q (FTDP-17). The genes associated with parkinsonism are microtubule associated protein tau (MAPT), progranulin (GRN or PGRN), and chromosome 9 open reading frame 72 (C9ORF72) repeat expansion. The neural substrate of parkinsonism remains to be unveiled. Dopamine transporter (DAT) imaging revealed decreased uptake of DAT, and imaging findings indicated atrophic changes of the basal ganglia. Parkinsonism can be an important feature in FTLD and, therefore, increased attention is needed on the subject.
Keywords: Frontotemporal dementia; Frontotemporal lobar degeneration; Parkinsonism.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
![Figure 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9361/4027647/c64720b9f9f9/jmd-6-1-1-1f1.gif)
Classification of frontotemporal lobar degeneration based on the clinical manifestations. FTLD: frontotemporal lobar denetation, bvFTD: behavioral variant frontotemporal dementia, PNFA: progressive nonfluent aphasia, SD: semantic dementia, PSP: progressive supranuclear palsy, CBD: corticobasal degeneration, FTDP-17: frontotemporal dementia with parkinsonism linked to chromosome 17, FTD-MND: frontotemporal dementia-motor neuron disease.
![Figure 2.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9361/4027647/3dc98c85f55e/jmd-6-1-1-1f2.gif)
Brain MRI in frontotemporal dementia patients. A: A patient with behavioral variant frontotemporal dementia who presented with parkinsonism showed frontal and temporal atrophy. B: The presence of symmetric atrophy in bilateral temporal lobes was seen in a semantic dementia case. C: A patient with progressive nonfluent aphasia demonstrated the focal atrophy of the left perisylvian area.
![Figure 3.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9361/4027647/702f412f8c6d/jmd-6-1-1-1f3.gif)
Positron emission tomography (PET) images in a frontotemporal dementia (FTD) patient. This FTD patient who presented with parkinsonism demonstrated frontotemporal hypometabolism in fluorodeoxyglucose positron emission tomography (FDG PET) (A). [11C] Pittsburgh compound-B (PIB) PET showed little PIB retention.
Similar articles
-
Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM; Consortium for Frontotemporal Lobar Degeneration. Cairns NJ, et al. Acta Neuropathol. 2007 Jul;114(1):5-22. doi: 10.1007/s00401-007-0237-2. Epub 2007 Jun 20. Acta Neuropathol. 2007. PMID: 17579875 Free PMC article.
-
Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE, Matthews BR. Seltman RE, et al. CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. CNS Drugs. 2012. PMID: 22950490 Review.
-
Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review.
Pan XD, Chen XC. Pan XD, et al. Transl Neurodegener. 2013 Apr 19;2(1):8. doi: 10.1186/2047-9158-2-8. Transl Neurodegener. 2013. PMID: 23597030 Free PMC article.
-
Tipton PW, Deutschlaender AB, Savica R, Heckman MG, Brushaber DE, Dickerson BC, Gavrilova RH, Geschwind DH, Ghoshal N, Graff-Radford J, Graff-Radford NR, Grossman M, Hsiung GR, Huey ED, Irwin DJ, Jones DT, Knopman DS, McGinnis SM, Rademakers R, Ramos EM, Forsberg LK, Heuer HW, Onyike C, Tartaglia C, Domoto-Reilly K, Roberson ED, Mendez MF, Litvan I, Appleby BS, Grant I, Kaufer D, Boxer AL, Rosen HJ, Boeve BF, Wszolek ZK; ALLFTD Consortium. Tipton PW, et al. Neurology. 2022 Sep 13;99(11):e1154-e1167. doi: 10.1212/WNL.0000000000200860. Epub 2022 Jul 5. Neurology. 2022. PMID: 35790423 Free PMC article.
-
Lladó A, Sánchez-Valle R, Rey MJ, Ezquerra M, Tolosa E, Ferrer I, Molinuevo JL; Catalan collaborative Study Group for FTLD. Lladó A, et al. J Neurol. 2008 Apr;255(4):488-94. doi: 10.1007/s00415-008-0565-8. Epub 2008 Mar 25. J Neurol. 2008. PMID: 18357425
Cited by
-
Xu Y, Liu X, Shen J, Tian W, Fang R, Li B, Ma J, Cao L, Chen S, Li G, Tang H. Xu Y, et al. Aging Dis. 2018 Aug 1;9(4):696-705. doi: 10.14336/AD.2018.0208. eCollection 2018 Aug. Aging Dis. 2018. PMID: 30090657 Free PMC article.
-
Dupont AC, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Tronel C, Arlicot N. Dupont AC, et al. Int J Mol Sci. 2017 Apr 7;18(4):785. doi: 10.3390/ijms18040785. Int J Mol Sci. 2017. PMID: 28387722 Free PMC article. Review.
-
Battista P, Capozzo R, Rizzo G, Zecca C, Anastasia A, De Blasi R, Logroscino G. Battista P, et al. Clin Interv Aging. 2019 Apr 26;14:727-733. doi: 10.2147/CIA.S197484. eCollection 2019. Clin Interv Aging. 2019. PMID: 31114177 Free PMC article.
-
Maldonado P, Bessaguet H, Chol C, Giraux P, Lafaie L, Adham A, David R, Celarier T, Ojardias E. Maldonado P, et al. Toxins (Basel). 2024 Aug 16;16(8):365. doi: 10.3390/toxins16080365. Toxins (Basel). 2024. PMID: 39195775 Free PMC article.
-
Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.
Lee JY, Marian OC, Don AS. Lee JY, et al. Neuromolecular Med. 2021 Mar;23(1):1-24. doi: 10.1007/s12017-021-08644-4. Epub 2021 Feb 7. Neuromolecular Med. 2021. PMID: 33550528 Review.
References
-
- Pick A. Uber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr. 1892:165–167.
-
- Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–1554. - PubMed
-
- Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56:399–406. - PubMed
-
- Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:41–48. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous